The following are the full annotation and the short annotation (used for network visualisation) assigned to this Mass2Motif.
Annotation: Diethylamino /dimethylaminoethyl substructure
Short Annotation: Diethylamino /dimethylaminoethyl substructure
The following table shows the fragment and loss features that are explained by this Mass2Motifs and their corresponding probabilities. After thresholding to save the model, the total probability left in this motif is 1.0000000000000009. The column MAGMa Substructure Annotation shows substructures and the counts of MAGMa annotations for documents linked above threshold to this motif in this experiment. Hovering over each MAGMa substructure shows a plot of the substructure.
| Term name | Count in motif | Percentage in motif | Percentage in experiment | Absolute difference |
|---|---|---|---|---|
| Hydrocarbon derivative | 57 | 86.4 | 78.1 | 8.2 |
| Organopnictogen compound | 50 | 75.8 | 46.6 | 29.2 |
| Organic nitrogen compound | 48 | 72.7 | 60.8 | 11.9 |
| Organonitrogen compound | 48 | 72.7 | 60.8 | 12.0 |
| Organic oxygen compound | 44 | 66.7 | 69.8 | 3.1 |
| Organooxygen compound | 43 | 65.2 | 68.4 | 3.2 |
| Amine | 39 | 59.1 | 25.0 | 34.0 |
| Tertiary amine | 31 | 47.0 | 14.6 | 32.4 |
| Tertiary aliphatic amine | 30 | 45.5 | 13.7 | 31.7 |
| Organic oxide | 29 | 43.9 | 62.0 | 18.1 |
| Azacycle | 28 | 42.4 | 46.4 | 4.0 |
| Benzenoid | 27 | 40.9 | 45.0 | 4.1 |
| Aromatic heteropolycyclic compound | 23 | 34.8 | 40.3 | 5.4 |
| Heteroaromatic compound | 23 | 34.8 | 36.8 | 2.0 |
| Carboxylic acid derivative | 19 | 28.8 | 35.2 | 6.4 |
| Ether | 18 | 27.3 | 30.9 | 3.7 |
| Monocyclic benzene moiety | 18 | 27.3 | 26.6 | 0.6 |
| Aromatic homomonocyclic compound | 18 | 27.3 | 9.6 | 17.7 |
| Carbonyl group | 17 | 25.8 | 41.3 | 15.6 |
| Alkyl aryl ether | 16 | 24.2 | 24.7 | 0.5 |
| Carboxamide group | 15 | 22.7 | 24.1 | 1.4 |
| Aralkylamine | 13 | 19.7 | 10.5 | 9.2 |
| Pyridine | 13 | 19.7 | 8.5 | 11.2 |
| Amino acid or derivatives | 13 | 19.7 | 10.7 | 9.0 |
| Primary amine | 13 | 19.7 | 6.3 | 13.4 |
| Organoheterocyclic compound | 11 | 16.7 | 38.0 | 21.4 |
| Aniline or substituted anilines | 11 | 16.7 | 3.6 | 13.1 |
| Monocarboxylic acid or derivatives | 10 | 15.2 | 19.7 | 4.5 |
| Carboxylic acid ester | 10 | 15.2 | 13.9 | 1.2 |
| Secondary carboxylic acid amide | 10 | 15.2 | 15.3 | 0.1 |
| Secondary amine | 10 | 15.2 | 5.3 | 9.9 |
| Benzoyl | 10 | 15.2 | 7.2 | 7.9 |
| Organic 1,3-dipolar compound | 9 | 13.6 | 9.9 | 3.7 |
| Propargyl-type 1,3-dipolar organic compound | 9 | 13.6 | 9.9 | 3.7 |
| Primary aliphatic amine | 9 | 13.6 | 2.8 | 10.8 |
| Primary aromatic amine | 9 | 13.6 | 3.3 | 10.4 |
| Oxacycle | 8 | 12.1 | 27.5 | 15.4 |
| Alcohol | 8 | 12.1 | 18.9 | 6.8 |
| Piperidine | 8 | 12.1 | 9.4 | 2.8 |
| Organohalogen compound | 8 | 12.1 | 14.1 | 1.9 |
| Aryl halide | 8 | 12.1 | 10.8 | 1.3 |
| Carboximidic acid derivative | 7 | 10.6 | 4.9 | 5.7 |
| Aryl chloride | 7 | 10.6 | 7.2 | 3.4 |
| Phenol ether | 7 | 10.6 | 13.0 | 2.4 |
| Organochloride | 7 | 10.6 | 8.7 | 1.9 |
| Secondary aliphatic amine | 7 | 10.6 | 4.4 | 6.2 |
| Phenoxy compound | 7 | 10.6 | 11.4 | 0.7 |
| Secondary alcohol | 6 | 9.1 | 14.3 | 5.2 |
| Fatty acyl | 6 | 9.1 | 5.9 | 3.2 |
| 1,2-aminoalcohol | 6 | 9.1 | 3.3 | 5.8 |
| Tertiary carboxylic acid amide | 6 | 9.1 | 12.0 | 2.9 |
| Aromatic heteromonocyclic compound | 6 | 9.1 | 14.3 | 5.2 |
| Carboximidic acid | 6 | 9.1 | 3.9 | 5.2 |
| Imidolactam | 6 | 9.1 | 3.8 | 5.3 |
| Dialkyl ether | 5 | 7.6 | 7.7 | 0.1 |
| Pyrrole | 5 | 7.6 | 7.6 | 0.0 |
| Indole or derivatives | 5 | 7.6 | 5.0 | 2.6 |
| Indole | 5 | 7.6 | 6.9 | 0.7 |
| Benzamide | 5 | 7.6 | 1.8 | 5.8 |
| Aminophenyl ether | 5 | 7.6 | 0.7 | 6.9 |
| Anisole | 5 | 7.6 | 13.4 | 5.8 |
| Aliphatic homopolycyclic compound | 5 | 7.6 | 3.7 | 3.9 |
| Azole | 5 | 7.6 | 8.1 | 0.5 |
| N-acyl-amine | 4 | 6.1 | 2.3 | 3.8 |
| Fatty amide | 4 | 6.1 | 3.0 | 3.1 |
| Alpha-amino acid amide | 4 | 6.1 | 4.1 | 2.0 |
| Amphetamine or derivatives | 4 | 6.1 | 2.8 | 3.3 |
| N-acyl-alpha amino acid or derivatives | 4 | 6.1 | 6.4 | 0.3 |
| 3-alkylindole | 4 | 6.1 | 4.9 | 1.2 |
| 1-hydroxy-2-unsubstituted benzenoid | 4 | 6.1 | 8.9 | 2.8 |
| Phenol | 4 | 6.1 | 6.8 | 0.8 |
| Methoxybenzene | 4 | 6.1 | 7.9 | 1.8 |
| Methoxyaniline | 4 | 6.1 | 0.8 | 5.3 |
| Tertiary aliphatic/aromatic amine | 4 | 6.1 | 2.2 | 3.9 |
| Dialkylarylamine | 4 | 6.1 | 3.4 | 2.6 |
| Aminobenzoic acid or derivatives | 4 | 6.1 | 0.6 | 5.5 |
| Benzoate ester | 4 | 6.1 | 1.5 | 4.6 |
| Halobenzene | 4 | 6.1 | 6.1 | 0.1 |
| Lactone | 3 | 4.5 | 12.7 | 8.1 |
| 2-piperidinecarboxamide | 3 | 4.5 | 0.2 | 4.4 |
| Phenylbutylamine | 3 | 4.5 | 0.8 | 3.7 |
| Quinoline-2-carboxamide | 3 | 4.5 | 0.1 | 4.5 |
| 2-heteroaryl carboxamide | 3 | 4.5 | 1.2 | 3.3 |
| Pyridine carboxylic acid or derivatives | 3 | 4.5 | 1.7 | 2.8 |
| Piperidinecarboxamide | 3 | 4.5 | 2.0 | 2.5 |
| Quinoline | 3 | 4.5 | 0.9 | 3.6 |
| Primary carboxylic acid amide | 3 | 4.5 | 1.3 | 3.2 |
| Asparagine or derivatives | 3 | 4.5 | 0.1 | 4.5 |
| Substituted pyrrole | 3 | 4.5 | 3.9 | 0.7 |
| Aminopyridine | 3 | 4.5 | 0.7 | 3.8 |
| Alpha-amino acid or derivatives | 3 | 4.5 | 9.6 | 5.1 |
| Alkyldiarylamine | 3 | 4.5 | 0.5 | 4.0 |
| Organosulfur compound | 3 | 4.5 | 7.6 | 3.0 |
| Sulfonyl | 3 | 4.5 | 4.0 | 0.6 |
| Benzenesulfonyl group | 3 | 4.5 | 2.7 | 1.9 |
| Quinolone | 3 | 4.5 | 0.3 | 4.3 |
| Aryl alkyl ketone | 3 | 4.5 | 3.2 | 1.3 |
| Chlorobenzene | 3 | 4.5 | 4.2 | 0.4 |
| Thiadiazole | 3 | 4.5 | 0.1 | 4.4 |
| Oxazinane | 3 | 4.5 | 0.8 | 3.7 |
| Morpholine | 3 | 4.5 | 0.8 | 3.7 |
| Macrolide | 2 | 3.0 | 1.6 | 1.4 |
| Aliphatic heteropolycyclic compound | 2 | 3.0 | 3.5 | 0.5 |
| Oxirane | 2 | 3.0 | 1.2 | 1.9 |
| Indoloquinoline | 2 | 3.0 | 0.3 | 2.8 |
| Isoindole or derivatives | 2 | 3.0 | 0.7 | 2.4 |
| Alkaloid or derivatives | 2 | 3.0 | 1.1 | 1.9 |
| Pyrroloquinoline | 2 | 3.0 | 0.3 | 2.7 |
| Ergoline skeleton | 2 | 3.0 | 0.1 | 2.9 |
| Benzoquinoline | 2 | 3.0 | 0.5 | 2.5 |
| Lactam | 2 | 3.0 | 10.3 | 7.3 |
| P-aminophenol | 2 | 3.0 | 0.1 | 3.0 |
| Aminophenol | 2 | 3.0 | 0.2 | 2.9 |
| 4-aminoquinoline | 2 | 3.0 | 0.1 | 2.9 |
| Phenylmethylamine | 2 | 3.0 | 0.8 | 2.2 |
| Haloquinoline | 2 | 3.0 | 0.7 | 2.3 |
| Benzylamine | 2 | 3.0 | 1.0 | 2.1 |
| Chloroquinoline | 2 | 3.0 | 0.1 | 2.9 |
| Fatty acid ester | 2 | 3.0 | 2.5 | 0.5 |
| N,n-dialkyl-m-toluamide | 2 | 3.0 | 0.0 | 3.0 |
| Benzoic acid or derivatives | 2 | 3.0 | 3.3 | 0.2 |
| Aminobenzamide | 2 | 3.0 | 0.2 | 2.8 |
| Phenylpropane | 2 | 3.0 | 1.6 | 1.4 |
| Benzenesulfonamide | 2 | 3.0 | 1.9 | 1.2 |
| Organosulfonic acid amide | 2 | 3.0 | 2.6 | 0.5 |
| Aminosulfonyl compound | 2 | 3.0 | 3.1 | 0.1 |
| Organosulfonic acid or derivatives | 2 | 3.0 | 3.6 | 0.5 |
| Organic sulfonic acid or derivatives | 2 | 3.0 | 3.6 | 0.5 |
| 1-hydroxy-4-unsubstituted benzenoid | 2 | 3.0 | 5.3 | 2.3 |
| Ketone | 2 | 3.0 | 11.9 | 8.8 |
| Aryl ketone | 2 | 3.0 | 4.6 | 1.6 |
| Pheniramine | 2 | 3.0 | 0.2 | 2.9 |
| Aryl thioether | 2 | 3.0 | 1.3 | 1.7 |
| Diarylthioether | 2 | 3.0 | 0.8 | 2.2 |
| Phenothiazine | 2 | 3.0 | 0.4 | 2.6 |
| Thioether | 2 | 3.0 | 3.2 | 0.2 |
| Para-thiazine | 2 | 3.0 | 0.4 | 2.6 |
| Imidazole | 2 | 3.0 | 4.0 | 1.0 |
| Secondary aliphatic/aromatic amine | 2 | 3.0 | 1.4 | 1.7 |
| Aminoquinoline | 2 | 3.0 | 0.8 | 2.2 |
| Oxane | 1 | 1.5 | 3.4 | 1.9 |
| N-alkylindole | 1 | 1.5 | 0.7 | 0.8 |
| N-methylpyrrole | 1 | 1.5 | 0.5 | 1.0 |
| Benzopyran | 1 | 1.5 | 10.7 | 9.2 |
| Pyridinone | 1 | 1.5 | 2.6 | 1.1 |
| Cytisine | 1 | 1.5 | 2.0 | 0.5 |
| N-acyl-piperidine | 1 | 1.5 | 3.4 | 1.9 |
| Coumarin | 1 | 1.5 | 5.6 | 4.0 |
| Pyranone | 1 | 1.5 | 10.1 | 8.6 |
| Pyran | 1 | 1.5 | 10.7 | 9.2 |
| 1-benzopyran | 1 | 1.5 | 10.7 | 9.2 |
| Macrolide lactam | 1 | 1.5 | 0.5 | 1.0 |
| Macrolactam | 1 | 1.5 | 1.7 | 0.2 |
| Cyclic depsipeptide | 1 | 1.5 | 0.5 | 1.0 |
| Phosphoric acid ester | 1 | 1.5 | 0.6 | 0.9 |
| Phosphoethanolamine | 1 | 1.5 | 0.3 | 1.2 |
| Dialkyl phosphate | 1 | 1.5 | 0.5 | 1.0 |
| Organic phosphoric acid derivative | 1 | 1.5 | 0.8 | 0.7 |
| Diacylglycero-3-phosphoethanolamine | 1 | 1.5 | 0.3 | 1.2 |
| Alkyl phosphate | 1 | 1.5 | 0.6 | 0.9 |
| Aliphatic acyclic compound | 1 | 1.5 | 1.9 | 0.4 |
| Dicarboxylic acid or derivatives | 1 | 1.5 | 4.2 | 2.6 |
| N-arylpiperazine | 1 | 1.5 | 1.6 | 0.1 |
| Phenylpiperazine | 1 | 1.5 | 0.6 | 0.9 |
| Azepine | 1 | 1.5 | 0.9 | 0.6 |
| Dibenzazepine | 1 | 1.5 | 0.3 | 1.2 |
| Sulfone | 1 | 1.5 | 0.5 | 1.0 |
| Dibenzocycloheptene | 1 | 1.5 | 0.1 | 1.4 |
| Aromatic homopolycyclic compound | 1 | 1.5 | 2.3 | 0.8 |
| Acetamide | 1 | 1.5 | 0.6 | 0.9 |
| N-acetylarylamine | 1 | 1.5 | 0.1 | 1.4 |
| Acylaminobenzoic acid or derivatives | 1 | 1.5 | 0.3 | 1.2 |
| Anilide | 1 | 1.5 | 1.6 | 0.1 |
| Acetanilide | 1 | 1.5 | 0.1 | 1.4 |
| N-arylamide | 1 | 1.5 | 1.7 | 0.2 |
| Vinylogous acid | 1 | 1.5 | 5.4 | 3.9 |
| Chromone | 1 | 1.5 | 3.1 | 1.6 |
| 2,2-dimethyl-1-benzopyran | 1 | 1.5 | 1.5 | 0.0 |
| Urea | 1 | 1.5 | 2.8 | 1.3 |
| Tertiary alcohol | 1 | 1.5 | 5.5 | 4.0 |
| Phenylpiperidine | 1 | 1.5 | 0.8 | 0.8 |
| Acetophenone | 1 | 1.5 | 0.4 | 1.2 |
| Pyrido-para-diazepine | 1 | 1.5 | 0.0 | 1.5 |
| 1,4-benzodiazepine | 1 | 1.5 | 0.3 | 1.2 |
| Cyclic carboximidic acid | 1 | 1.5 | 1.8 | 0.3 |
| Aliphatic homomonocyclic compound | 1 | 1.5 | 0.4 | 1.1 |
| Methylpyridine | 1 | 1.5 | 0.7 | 0.8 |
| Harman | 1 | 1.5 | 0.6 | 0.9 |
| Beta-carboline | 1 | 1.5 | 2.4 | 0.8 |
| Pyridoindole | 1 | 1.5 | 2.0 | 0.5 |
| C-nitro compound | 1 | 1.5 | 1.3 | 0.2 |
| Organic oxoazanium | 1 | 1.5 | 1.3 | 0.2 |
| Organic nitro compound | 1 | 1.5 | 1.4 | 0.1 |
| Organic zwitterion | 1 | 1.5 | 1.1 | 0.4 |
| Catechol | 1 | 1.5 | 0.8 | 0.7 |
| Nitrile | 1 | 1.5 | 1.0 | 0.5 |
| Allyl-type 1,3-dipolar organic compound | 1 | 1.5 | 1.4 | 0.1 |
| Hydroxycinnamic acid or derivatives | 1 | 1.5 | 0.3 | 1.2 |
| Nitrophenol | 1 | 1.5 | 0.1 | 1.4 |
| Nitroaromatic compound | 1 | 1.5 | 1.1 | 0.4 |
| Nitrobenzene | 1 | 1.5 | 0.7 | 0.8 |
| Carbonitrile | 1 | 1.5 | 1.0 | 0.5 |
| Bromobenzene | 1 | 1.5 | 0.3 | 1.3 |
| Organobromide | 1 | 1.5 | 0.7 | 0.8 |
| 2-bromoaniline | 1 | 1.5 | 0.0 | 1.5 |
| Aryl bromide | 1 | 1.5 | 0.7 | 0.9 |
| Indolyl carboxylic acid derivative | 1 | 1.5 | 0.6 | 0.9 |
| N-substituted-alpha-amino acid | 1 | 1.5 | 1.3 | 0.2 |
| Amino acid | 1 | 1.5 | 2.9 | 1.4 |
| Carboxylic acid | 1 | 1.5 | 13.3 | 11.8 |
| N-acyl-alpha-amino acid | 1 | 1.5 | 4.4 | 2.9 |
| Alpha-oligopeptide | 1 | 1.5 | 0.8 | 0.7 |
| Alanine or derivatives | 1 | 1.5 | 1.3 | 0.2 |
| Phenylalanine or derivatives | 1 | 1.5 | 1.6 | 0.1 |
| Acetal | 1 | 1.5 | 4.4 | 2.9 |
| Styrene | 1 | 1.5 | 1.8 | 0.3 |
| Benzodioxole | 1 | 1.5 | 1.2 | 0.3 |
| 6-alkylaminopurine | 1 | 1.5 | 0.3 | 1.2 |
| Pyrimidine | 1 | 1.5 | 4.5 | 3.0 |
| Aminopyrimidine | 1 | 1.5 | 2.3 | 0.8 |
| Primary alcohol | 1 | 1.5 | 5.5 | 4.0 |
| N-substituted imidazole | 1 | 1.5 | 3.2 | 1.7 |
| Imidazoquinoline | 1 | 1.5 | 0.0 | 1.5 |
| Imidazopyridine | 1 | 1.5 | 0.1 | 1.4 |
| Imidazo-[4,5-c]pyridine | 1 | 1.5 | 0.0 | 1.5 |
| Alpha-aminoketone | 1 | 1.5 | 0.1 | 1.4 |
| Alkyl-phenylketone | 1 | 1.5 | 1.0 | 0.5 |
| Xylene | 1 | 1.5 | 0.8 | 0.7 |
| M-xylene | 1 | 1.5 | 0.7 | 0.8 |
Two bar plots will appear below this message. The first shows the proportion of the total intensity of these features explained by this Mass2Motif. Red bars show the total intensity (across the whole dataset), blue bars show the proportion explained by the selected Mass2Motif. The second shows the number of times each feature in this Mass2Motif appears in the documents associated with this Mass2Motif.
The following table lists all fragmentation spectra that are explained by this Mass2Motif at the threshold specified in the experiment option.
| Fragmentation spectra | Precursor Mass | Parent mass | Annotation | Probability | Overlap Score |
|---|---|---|---|---|---|
| CCMSLIB00000068211.ms | 313.1774 | 313.1774 | Ecklonialactone A M+Na | 1.000 | 0.025 |
| CCMSLIB00000085050.ms | 671.3915 | 671.3915 | MLS001195635-01!SAQUINAVIR MESYLATE M+H | 0.908 | 0.184 |
| CCMSLIB00000001676.ms | 694.4150 | 694.4150 | Arenamide A M+Na | 0.708 | 0.058 |
| CCMSLIB00000085067.ms | 671.3915 | 671.3915 | MLS001401395-01!SAQUINAVIR MESYLATE M+H | 0.702 | 0.107 |
| CCMSLIB00000085003.ms | 404.2333 | 404.2333 | MLS001148102-01! M+H | 0.682 | 0.134 |
| CCMSLIB00000079268.ms | 671.3915 | 671.3915 | SAQUINAVIR MESYLATE [M+H] | 0.667 | 0.139 |
| CCMSLIB00000080039.ms | 495.1681 | 495.1681 | MLS001032277-01! M+H | 0.616 | 0.017 |
| CCMSLIB00000085987.ms | 356.1524 | 356.1524 | MLS001332570-01!Amodiaquin dihydrochloride dihydrate6398-98-7 M+H | 0.588 | 0.517 |
| CCMSLIB00000577626.ms | 608.3654 | 608.3654 | Destruxin_E1_25015_dereplictor_pv_4.82044e-20 M+H | 0.568 | 0.029 |
| CCMSLIB00000085813.ms | 224.1281 | 224.1281 | MLS001146918-01! M+H | 0.500 | 0.509 |
| CCMSLIB00000071742.ms | 650.4755 | 650.4755 | phosphatidylethanolamine (14:0/15:0) M+H | 0.500 | 0.011 |
| CCMSLIB00000086136.ms | 192.1383 | 192.1383 | "MLS001333179-01!N,N-Diethyl-3-methylbenzamide134-62-3" M+H | 0.466 | 0.505 |
| CCMSLIB00000085194.ms | 356.1524 | 356.1524 | MLS001304065-01! M+H | 0.420 | 0.449 |
| CCMSLIB00000579756.ms | 192.1383 | 192.1383 | DEET M+H | 0.339 | 0.404 |
| CCMSLIB00000077022.ms | 236.1757 | 236.1757 | Pronestyl [M+H] | 0.325 | 0.440 |
| CCMSLIB00000085484.ms | 193.1335 | 193.1335 | MLS001056761-01! M+H | 0.316 | 0.401 |
| CCMSLIB00000085108.ms | 180.1747 | 180.1747 | MLS001332605-01!Memantine hydrochloride41100-52-1 M+H | 0.233 | 0.440 |
| CCMSLIB00000085403.ms | 315.1623 | 315.1623 | MLS001074205-01!17321-77-6 M+H | 0.214 | 0.461 |
| CCMSLIB00000084885.ms | 329.1530 | 329.1530 | MLS001076118-01!TIAPRIDE HYDROCHLORIDE M+H | 0.204 | 0.440 |
| CCMSLIB00000084751.ms | 180.1747 | 180.1747 | MLS001401420-01! M+H | 0.202 | 0.398 |
| CCMSLIB00000078632.ms | 344.2333 | 344.2333 | Dibucaine (Cinchocaine) HCl [M+H] | 0.199 | 0.440 |
| CCMSLIB00000085506.ms | 236.1757 | 236.1757 | MLS001148635-01!Pronestyl M+H | 0.199 | 0.440 |
| CCMSLIB00000085515.ms | 180.1747 | 180.1747 | "MLS001074335-01!(3,5-dimethyl-1-adamantyl)amine nitrate" M+H | 0.199 | 0.398 |
| CCMSLIB00000085044.ms | 264.1958 | 264.1958 | MLS001148168-01!BUTETHAMATE CITRATE M+H | 0.183 | 0.440 |
| CCMSLIB00000085499.ms | 264.1747 | 264.1747 | MLS001074210-01!Protriptyline M+H | 0.183 | 0.398 |
| CCMSLIB00000579679.ms | 214.0896 | 214.0896 | N-Butylbenzenesulfonamide M+H | 0.173 | 0.398 |
| CCMSLIB00000086183.ms | 344.2333 | 344.2333 | MLS001076275-01!DIBUCAINE HYDROCHLORIDE M+H | 0.170 | 0.440 |
| CCMSLIB00000085301.ms | 344.2333 | 344.2333 | MLS001148085-01!85-79-0 M+H | 0.169 | 0.440 |
| CCMSLIB00000078010.ms | 399.2191 | 399.2191 | Sunitinib Malate (Sutent) [M+H] | 0.166 | 0.440 |
| CCMSLIB00000084745.ms | 278.1863 | 278.1863 | MLS001148141-01!N-ACETYLPROCAINAMIDE HYDROCHLORIDE M+H | 0.162 | 0.440 |
| CCMSLIB00000079645.ms | 449.1377 | 449.1377 | "MLS001032339-01!2-[(5-hydroxy-2,2-dimethyl-4-oxo-3H-chromen-7-yl)oxy]-N-[2-(4-sulfamoylphenyl)ethyl]acetamide" M+H | 0.160 | 0.398 |
| CCMSLIB00000086106.ms | 241.1699 | 241.1699 | MLS001148181-01!Pheniramine maleate salt M+H | 0.157 | 0.447 |
| CCMSLIB00000078628.ms | 237.1598 | 237.1598 | Procaine (Novocaine) HCl [M+H] | 0.152 | 0.440 |
| CCMSLIB00000077021.ms | 237.1598 | 237.1598 | Procaine (Novocaine) aka 2-(diethylamino)ethyl 4-aminobenzoate M+H | 0.142 | 0.440 |
| CCMSLIB00000085444.ms | 241.1699 | 241.1699 | MLS002207118-01!Pheniramine maleate salt132-20-7 M+H | 0.140 | 0.447 |
| CCMSLIB00000085671.ms | 341.2336 | 341.2336 | MLS000069833-01!TRANS-DIHYDROLISURIDE M+H | 0.138 | 0.444 |
| CCMSLIB00000085421.ms | 341.1415 | 341.1415 | "MLS000860079-01!L-741,626" M+H | 0.136 | 0.009 |
| CCMSLIB00000084825.ms | 300.1473 | 300.1473 | MLS001074186-01! M+H | 0.131 | 0.451 |
| CCMSLIB00000085647.ms | 285.1420 | 285.1420 | MLS001148436-01! M+H | 0.126 | 0.445 |
| CCMSLIB00000085592.ms | 327.1526 | 327.1526 | MLS002153883-01!Acetopromazine maleate salt3598-37-6 M+H | 0.112 | 0.449 |
| CCMSLIB00000085189.ms | 335.1965 | 335.1965 | MLS002154082-01!Nitrocaramiphen hydrochloride M+H | 0.111 | 0.440 |
| CCMSLIB00000079135.ms | 422.2551 | 422.2551 | "6H-Pyrido[2,3-b][1,4]benzodiazepin-6-one, 11-[[2-[(diethylamino)methyl]-1-piperidinyl]acetyl]-5,11-dihydro- [CAS]" [M+H] | 0.106 | 0.398 |
| CCMSLIB00000079874.ms | 208.1332 | 208.1332 | MLS000863632-01!3-phenyl-2-(trimethylazaniumyl)propanoate M+H | 0.105 | 0.078 |
| CCMSLIB00000085452.ms | 317.1642 | 317.1642 | MLS002207126-01!Timolol maleate salt26921-17-5 M+H | 0.105 | 0.440 |
| CCMSLIB00000086000.ms | 317.1642 | 317.1642 | MLS000028539-01!TIMOLOL MALEATE M+H | 0.103 | 0.398 |
| CCMSLIB00000084749.ms | 319.1030 | 319.1030 | MLS001148603-01!69-09-0 M+H | 0.102 | 0.412 |
| CCMSLIB00000085644.ms | 310.2741 | 310.2741 | MLS001074064-01!Bentyl M+H | 0.101 | 0.440 |
| CCMSLIB00000086134.ms | 317.1642 | 317.1642 | MLS001076135-01!Timolol maleate salt M+H | 0.099 | 0.398 |
| CCMSLIB00000078734.ms | 268.1808 | 268.1808 | NCGC00160349-01!BREVICARINE M+H | 0.093 | 0.408 |
| CCMSLIB00000086138.ms | 319.1030 | 319.1030 | MLS000595399-01![3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-ammonium M+H | 0.090 | 0.454 |
| CCMSLIB00000078586.ms | 306.1084 | 306.1084 | Entacapone [M+H] | 0.089 | 0.398 |
| CCMSLIB00000078303.ms | 295.2016 | 295.2016 | Proparacaine HCl [M+H] | 0.089 | 0.440 |
| CCMSLIB00000078941.ms | 180.1747 | 180.1747 | "(3R,5S)-3,5-dimethyladamantan-1-amine" [M+H] | 0.082 | 0.398 |
| CCMSLIB00000086141.ms | 344.0968 | 344.0968 | MLS002153965-01!Bromopride4093-35-0 M+H | 0.080 | 0.442 |
| CCMSLIB00000223902.ms | 423.2027 | 423.2027 | Sevadicin M+H | 0.079 | 0.009 |
| CCMSLIB00000080181.ms | 274.1438 | 274.1438 | "MLS002473214-01!(2E,4E)-5-(1,3-benzodioxol-5-yl)-N-(2-methylpropyl)penta-2,4-dienamide" M+H | 0.077 | 0.461 |
| CCMSLIB00000085739.ms | 180.1747 | 180.1747 | MLS000069661-01!1-(1-ADAMANTYL)ETHYLAMINE HYDROCHLORIDE M+H | 0.075 | 0.398 |
| CCMSLIB00000085460.ms | 219.1492 | 219.1492 | MLS002695961-01!104015-29-4 M+H | 0.075 | 0.401 |
| CCMSLIB00000079576.ms | 220.1193 | 220.1193 | MLS001074742-01! M+H | 0.061 | 0.078 |
| CCMSLIB00000085395.ms | 318.2428 | 318.2428 | MLS002222187-01!548-66-3 M+H | 0.061 | 0.398 |
| CCMSLIB00000085381.ms | 241.1448 | 241.1448 | MLS000083577-01!Imiquimod M+H | 0.059 | 0.398 |
| CCMSLIB00000579548.ms | 240.1150 | 240.1150 | 0546_Bupropion M+H | 0.057 | 0.461 |
| CCMSLIB00000084879.ms | 208.1696 | 208.1696 | MLS002153485-01!R(-)-Me5 hydriodide M+H | 0.057 | 0.398 |
| CCMSLIB00000077047.ms | 295.2016 | 295.2016 | Proxymetacaine [M+H] | 0.055 | 0.398 |
| CCMSLIB00000006519.ms | 319.1030 | 319.1030 | Chlorpromazine M+H | 0.053 | 0.398 |
| CCMSLIB00000084798.ms | 260.1757 | 260.1757 | MLS001334045-01!Primaquine Diphosphate63-45-6 M+H | 0.052 | 0.404 |
The fragmentation spectra of molecules explained by this Mass2Motif are plotted below. Features (fragments and losses) explained by this Mass2Motif will be coloured red, while parent ion is coloured in blue. Click Next and Previous to cycle through the fragmentation spectra.